Mangoceuticals (MGRX) Return on Sales (2023 - 2026)

Mangoceuticals' Return on Sales history runs 4 years deep, the most recent figure standing at 0.5% for Q1 2026.

• In Q1 2026, Return on Sales fell 6.0% year-over-year to 0.5%; the TTM figure through Mar 2026 stood at 0.46% (down 24.0% YoY), while the FY2025 annual figure was 0.45%, down 31.0% from the prior year.
• Return on Sales came in at 0.5% for Q1 2026 at Mangoceuticals, down from 0.29% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.07% in Q3 2023 to a low of 0.9% in Q3 2025.
• A 4-year average of 0.28% and a median of 0.19% in 2024 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales grew 14 bps in 2024 and tumbled 75 bps in 2025, its largest moves.
• Mangoceuticals' Return on Sales stood at 0.11% in 2023, then sank by 76 bps to 0.19% in 2024, then plunged by 59 bps to 0.29% in 2025, then slumped by 71 bps to 0.5% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.5%, 0.29%, and 0.9% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison